in Head and Neck Cancer—30 Years of History


Reference

Lesion

No. of cases

Method

HPV-positivity

Types detected

Syrjänen et al. (1983a, b, c, d)

SCC

40

ICH

8/40

20 %
 
Syrjänen et al. (1983a, b, c, d)

SCC

1

ICH

0/1

0 %
 
Syrjänen et al. (1983a, b, c, d)

SCC

6

ICH

0/6

0 %
 
Jin and Toto (1984)

Verrucous Ca

7

ICH

0/7

0 %
 
Löning et al. (1985)

SCC

6

SB

3/6

50 %
 
de Villiers et al. (1985)

SCC

7

SB

3/7

43 %

2, 16

Adler-Storthz et al. (1986)

Verrucous Ca

9

ISH

1/9

11 %

2

Syrjänen et al. (1986)

SCC

2

ISH

1/2

100 %

16

de Villiers et al. (1986)

SCC

11

SB

4/11

36 %

2, 16

Löning et al. (1986)

SCC

6

ISH

3/6

50 %

11, 16

Milde and Löning (1986)

SCC

7

ISH

4/7

57 %

16

Maitland et al. (1987)

SCC

15

SB

7/15

47 %

16, unknown

Lookingbill et al. (1987)

SCC

1

DB

1/1

100 %

11, 16

Löning et al. (1987)

SCC

13

DB

5/13

38 %

6/11, 16/18

Ostrow et al. (1987)

SCC

3

SB

1/3

33 %

16

Dekmezian et al. (1987)

SCC

4

ISH

4/4

100 %
 
Gassenmaier and Hornstein (1988)

SCC

68

ISH

16/68

23 %

2, 6, 11, 16

Lee et al. (1988)

SCC

2

SB

1/2

50 %
 
Syrjänen et al. (1988)

SCC

51

ISH

6/51

12 %

16, 18

Brandsma and Abramson (1989)

SCC

39

SB

2/39

5 %
 
Chang et al. (1989)

SCC

17

SB

13/17

76 %
 
Maitland et al. (1989)

SCC

50

PCR

25/50

50 %

16

Demetric et al. (1990)

SCC

1

ISH, SB

1/1

100 %

16

Ishibashi et al. (1990)

SCC

6

SB

0/6

0 %
 
Kashima et al. (1990)

SCC

29

SB,ISH

6/29

21 %
 
Greer et al. (1990a, b)

SCC

2

DB

2/2

100 %

6/11, 16/18

Greer et al. (1990a, b)

Verrucous Ca

20

ISH

4/20

20 %

6/11, 16/18

Chang et al. (1990)

SCC

40

ISH, PCR
 
11/40 28 %

16(69 %), 6, 18

Kulski et al. 1990

SCC

5

SB

1/5

20 %

6/11, 16/18

Niedobitek et al. (1990)

SCC, tonsil

21

ISH

6/28

21 %

16

Arndt et al. (1991)

SCC

11

SB

7/11

64 %

6/11, 16/18

SCC, tonsil

9

SB

5/9

56 %

6/11, 16/18
 
Tsuchiya et al. (1991)

SCC

23

ISH, SB

3/23

13 %

Unknown

Abdelsayed et al. (1991)

SCC

36

ISH

2/36

6 %

6/11, 16/18

Palefsky et al. (1991)

SCC

25

PCR

8/25

32 %
 
Yeudall and Campo (1991)

SCC

39

SB
 
3/39 8 %

4, 16, 18

SCC

39

PCR

18/39

46 %
  
Watts et al. (1991)

SCC

23

SB, PCR, E6

16/23

70 %

6/11, 16/18

Verrucous Ca

49

SB, PCR

27/49
 
55 %

16/18

Shroyer et al. (1993)

SCC

10

ISH, PCR

1/10

10 %

16/18

Verrucous Ca

3

ISH, PCR

0/3

0 %
  
Zeuss et al. (1991)

SCC

15

ISH

0/15

0 %
 
Young and Min (1991)

SCC, Verrucous Ca

27

ISH

0/27

0 %
 
Adler-Storthz et al. (1992)

Verrucous Ca

9

ISH

3/9

33 %

2

Brachman et al. (1992)

SCC

11

PCR

1/11

9 %
 
Howell and Gallant (1992)

SCC

8

SB

1/8

13 %

16

SCC, metastasis

2

SB

1/2

50 %

16
 
Honig (1992)

SCC

12

ISH

7/12

60 %

6, 11, 16, 18

Shindoh et al. (1992)

SCC

24

SB

8/24

33 %

16, 18

Holladay and Gerald (1993)

SCC

37

DB

7/37

19 %

16, 18

Verrucous Ca

2

DB

0/2

0 %
  
Noble-Topham et al. (1993)

Verrucous Ca

25

PCR

12/25

48 %

6/11, 16, 18

Woods et al. (1993)

SCC

18

PCR, L1

14/18

78 %

6, 11, 16, 18

SCC metastasis

5

PCR

5/5 100 %

6, 11, 16, 18
  
Cox et al. (1993)

SCC

8

SB

4/8

50 %

16

Guitart et al. (1993)

Verrucous Ca

1

ISH

1/1

100 %

6




Table 2
Detection of HPV DNA in palatine tonsil carcinomas during the first 10 years after the original report








































































































































































































































































































































Technique
No of positive cases/total
6/11
16
18
16/18
16/33
31
33
X
First author (year)

SB
2/7 (29 %)
1
1
            
Brandsma and Abramson (1989) 29

SB
1/1 (100 %)
  
1a
           
Ishibashi et al. (1990) 30

ISH
6/28 (21 %)
  
6
            
Niedobitek et al. (1990)23

SB
1/1 (100 %)
  
1
            
Bercovitch et al. (1991)31

ISH
5/14 (36 %)
      
5
        
Arndt et al. (1992)24

PCR
10/10 (100 %)
  
4
    
1
  
3
2
Snijders et al. (1992)5

PCR
12/14 (86 %)
  
7
    
1
  
2
2
Snijders et al. (1994)25

PCR
2/3 (67 %)
                
Brachman et al. (1992)32

PCR, SB, Virapap
3/6 (50 %)
  
3
            
Watanabe et al. (1993)

SB + PCR
1/4 (25 %)
  
1
            
Ogura et al. (1993)33

PCR
2/4 (50 %)
  
2
            
Lewensohn-Fuchs et al. (1994)

PCR
3/7 (43 %)
              
ND
Brandwein et al. (1994)34

PCR + SB
9/15 (60 %)
  
8
          
1
Paz et al. (1997)9

SB + PCR
1/1 (100 %)
  
1
            
Turazza et al. (1997)35

PCR + SB
11/21 (52 %)
  
8
        
1
2
Andl et al. (1998)36

PCR + SB
19/44 (43 %)
3
40
            
Schwarz (1998)37

PCR
14/22 (63 %)
  
11
        
1
2
Wilczyski (1998)38

PCR
2/2 (100 %)
1a
   
1a
       
Badaracco et al. (2000a, b)39

PCR
6/13? (46)?
          
6b
   
Lopez-Lizarraga et al. (2000)40

SB
1/1 (100 %)
  
1
            
Ishiji et al. (2000)41

PCR
2/4 (50 %)
1
    
1
        
Badaracco (2000)1

PCR
32/52 (62 %)
                
Gillison et al. (2000)f7

PCR
26/60 (43 %)
  
26
  
1
        
Mellin et al. (2000)6

PCR
12/22 (55 %)
  
11
        
1
    

Total
221/432 (51 %)
7(3 %)
186 (84 %)
7(3 %)
3(1.4 %)
6(2.8 %)
9(4.6 %) 13(6 %)
      


aTriple infection 6, 16, 18

bOne infection with several HPV types 6, 18, 31, 35

cDouble infections HPV 5/16, ADX1/16

dHPV 12, HPV 59

eOne unidentified and HPV 59

fIncludes also tumors of lingual tonsils



Table 3
Detection of HPV DNA in sinonasal carcinomas during the first 10 years after the original report
















































































































































































Type of technique
HPV genotypes detected
Total (%)

Lesion
No.
6
6/11
11
16
16/18
18
Other
HPV+
Author and year

SCP
IH
1
              
100
Syrjänen et al. (1983a)

IP
ISH
14
1
5
5c
       
79
Syrjänen et al. (1987a)

SCC
ISH
3
  
3
          
100
  

SCC
ISH
40
  
4
  
1
  
1
  
2.5
  

SCC
  
2
  
1
          
50
Furuta et al. (1991)

SCC
PCR
8
1
            
12
Judd et al. (1991)

SCC
PCR
24
      
1
      
4
Kashima et al. (1992)

SCC
PCR
49
  
6
  
1
      
14
Furuta et al. (1992)

SCC
ISHb

35
1
1
  
3
        
Sarkar et al. (1992)

SCC
PCR
3
  
1
        
33
  
Tyan et al. (1993)

SCC
ISHb

22
            
57ba

86
Wu et al. (1993)


IP, inverted papilloma; SCC, squamous cell carcinoma; IH; immunohistochemistry; ISH, in situ hybridization; PCR, polymerase chain reaction; a19 cases HPV 57b-positive; bDouble infection with HPV6/11 and 16 in 13 cases; cDouble infection HPV 11&16 in 3 cases; ND, not clearly defined

SCC and papillomas

ISH+PCR



Table 4
Studies reporting on HPV detection in laryngeal squamous cell carcinomas during the first 10 years after the original report








































































































Method/histological type
HPV-positive
Number/total
%
Authors and year

Detection method
Histological type
HPV types detected

IHC
SCC
ND
13/36
36.1
Syrjänen et al. (1982)

SB
VCA
16
5/5
100
Abramson et al. (1985)

DB, SB
VCA
16
6/6
100
Brandsma et al. (1986)

SB
SCC
30
0/41
0
Kahn et al. (1986)

SB
SCC
16
1/36
3
Scheurlen et al. (1986)

SB
SCC
16
1/1
100
Stremlau et al. (1987)

DB
SCC
ND
0/4
0
Löning et al. (1987)

ISH
SCC
6, 11, 16
15/116
13
Syrjänen et al. (1987a, b)

SB, DB
SCC
6
1/1
100
Zarod et al. (1988)

IHC, SB
AOP, SCC
6
1/1
100
Kashima et al. (1988)

SB
SCC
11, 16
6/60
10
Brandsma and Abramson (1989)

PCR
SCC
16, 18
4/10
40

Only gold members can continue reading. Log In or Register to continue

Related posts:

Default ThumbnailImmunology and HPV Default ThumbnailTreatment in HPV-Induced Recurrent or Metastatic HNSCC Patterns and Biology of HPV-Associated HNSCC Default ThumbnailExpectations in HNSCC in HPV-Positive Tumors—The New Standard? Factors for Oral Infection with Human Papillomavirus

Stay updated, free articles. Join our Telegram channel
Tags:
Jun 25, 2017 | Posted by in ONCOLOGY | Comments Off on in Head and Neck Cancer—30 Years of History

Full access? Get Clinical Tree

 Get Clinical Tree app for offline access